GB201911868D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders - Google Patents
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersInfo
- Publication number
- GB201911868D0 GB201911868D0 GBGB1911868.6A GB201911868A GB201911868D0 GB 201911868 D0 GB201911868 D0 GB 201911868D0 GB 201911868 A GB201911868 A GB 201911868A GB 201911868 D0 GB201911868 D0 GB 201911868D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- pharmaceutical compositions
- novel compounds
- inflammatory disorders
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1911868.6A GB201911868D0 (en) | 2019-08-19 | 2019-08-19 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
PCT/EP2020/072715 WO2021032582A1 (en) | 2019-08-19 | 2020-08-13 | Pyrazolo[4,3-c]pyridine derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
EP20760394.5A EP4017590A1 (en) | 2019-08-19 | 2020-08-13 | Pyrazolo[4,3-c]pyridine derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
TW109128024A TW202115060A (en) | 2019-08-19 | 2020-08-18 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
ARP200102344A AR119792A1 (en) | 2019-08-19 | 2020-08-19 | PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY PATHOLOGIES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1911868.6A GB201911868D0 (en) | 2019-08-19 | 2019-08-19 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201911868D0 true GB201911868D0 (en) | 2019-10-02 |
Family
ID=68099572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1911868.6A Ceased GB201911868D0 (en) | 2019-08-19 | 2019-08-19 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4017590A1 (en) |
AR (1) | AR119792A1 (en) |
GB (1) | GB201911868D0 (en) |
TW (1) | TW202115060A (en) |
WO (1) | WO2021032582A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4091449A1 (en) * | 2021-05-19 | 2022-11-23 | Syngenta Crop Protection AG | Weed control method |
TW202317561A (en) * | 2021-07-01 | 2023-05-01 | 美商羅曼德生物治療公司 | Compounds having 1h-pyrazolo[4,3-c]pyridin-6-amino as therapeutic agents |
CN115557947B (en) * | 2021-07-02 | 2024-04-02 | 成都百裕制药股份有限公司 | Pyrazolo [4,3-c ] pyridine derivative and application thereof in medicine |
WO2023161327A1 (en) * | 2022-02-24 | 2023-08-31 | Galapagos Nv | Compound for use in and methods of treatment of inflammatory diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3235B1 (en) * | 2006-05-26 | 2018-03-08 | Astex Therapeutics Ltd | Pyrrolopyrimidine compounds and their uses |
AU2009211338B2 (en) * | 2008-02-06 | 2011-12-15 | Novartis Ag | Pyrrolo[2, 3-D] pyrimidines and use thereof as tyrosine kinase inhibitors |
WO2013017480A1 (en) * | 2011-07-29 | 2013-02-07 | Cellzome Limited | Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
-
2019
- 2019-08-19 GB GBGB1911868.6A patent/GB201911868D0/en not_active Ceased
-
2020
- 2020-08-13 WO PCT/EP2020/072715 patent/WO2021032582A1/en unknown
- 2020-08-13 EP EP20760394.5A patent/EP4017590A1/en active Pending
- 2020-08-18 TW TW109128024A patent/TW202115060A/en unknown
- 2020-08-19 AR ARP200102344A patent/AR119792A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW202115060A (en) | 2021-04-16 |
AR119792A1 (en) | 2022-01-12 |
WO2021032582A1 (en) | 2021-02-25 |
EP4017590A1 (en) | 2022-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202004025B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
IL255109A0 (en) | Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB201911868D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
ZA202002166B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
IL288375A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB201610056D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis | |
IL279397A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
EP4081201A4 (en) | Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders | |
IL286677A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
IL286688A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB201610055D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis | |
GB201907558D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
IL286685A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB201702603D0 (en) | Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
IL285751A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB202001421D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB202001420D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB201807222D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammation disorders | |
GB201905536D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of metabolic disorders | |
GB201817344D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB201817343D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB201702604D0 (en) | Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
GB201809836D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
IL287392A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases | |
GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |